Abstract

The article discusses modern representation about the mechanisms of development, the results of recently completed and the background for new studies of methods for treating chronic heart failure with preserved ejection fraction according to the literature and authors' own works.

Highlights

  • The article discusses modern representation about the mechanisms of development, the results of recently completed and the background for new studies of methods for treating chronic heart failure with preserved ejection fraction according to the literature and authors' own works

  • Использование блокатора рецепторов ангиокальциевых каналов у больных с гипертонической тензина II кандесартана может рассматриваться болезнью и хронической сердечной недостаточности (ХСН) с СФВ левого желудочка (ЛЖ), назначался аторваста- для снижения риска госпитализации пациентов с тин, который регулярно принимали 50,6% и 48,8% ХСН и СФВ ЛЖ

  • Shah K.S., Xu H., Matsouaka R.A. et al Heart Failure With нения в настоящее время исследования у боль- Preserved, Borderline, and Reduced Ejection Fraction: 5-Year ных с хронической сердечной недостаточности (ХСН) и СФВ левого желудочка (ЛЖ)

Read more

Summary

Introduction

The article discusses modern representation about the mechanisms of development, the results of recently completed and the background for new studies of methods for treating chronic heart failure with preserved ejection fraction according to the literature and authors' own works. В крупном рандомизированном проекте но снижаются ли при этом заболеваемость или TOPCAT у 3445 пациентов с ХСН и СФВ ЛЖ (≥45%)

Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.